Contract research and manufacturing organization VxP Pharma, along with sister company VxP Biologics, has expanded its lyophilization development and manufacturing capabilities. This expansion will serve their global pharma and biotech customer base, and will allow VxP to offer end-to-end development and manufacture of lyophilized cGLP tox materials, cGMP clinical trial material (CTM), and also commercial-scale finished product. “Our sterile products business has expanded rapidly in recent...